As of December 2024 Adaptimmune Therapeutics has a market cap of ₹13.14 Billion. This makes Adaptimmune Therapeutics the world's 8445th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 21st, 2024 the market cap of Adaptimmune Therapeutics was reported to be: